3rd Quarter - Termination
DELAHUNT GROUP, LLC for HEALIANCE PHARMACEUTICALS
Firm
Client
Income
$20,000
Expenses
—
Terminated
Aug 4, 2014
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Foreign Relations FOR
Issues related to issuance of supplemental OFAC license
Foreign entity interest: Foreign entity Digen Pharmaceuticals will benefit from work for the client.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DELAHUNT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.